NA, NAM, NMN, NR — Which “Anti-Aging Candidate” Should You Choose?
PART 01
Core Knowledge: What is NAD+ and Why Can’t It Be Directly Supplemented?

NAD+ is the cell’s “energy engine” and “repair manager,” involved in more than 500 physiological reactions.
Key functions include:
- Energy production: Mitochondria rely on NAD+ to generate energy. Without it, metabolism and physical performance falter.
- Anti-aging repair: Activates Sirtuins (longevity proteins) and PARP1 (DNA repair enzyme), clears DNA damage, and delays cellular senescence.
- Immune defense: Regulates immune cell activity, enhances antioxidant capacity, and eliminates harmful free radicals.
David Sinclair, Co-Director of Harvard Medical School’s Center for Biology of Aging, once said: “NAD+ is the most important molecule for maintaining youthfulness, and it is essential for life.” Unfortunately, NAD+ levels decline with age, triggering aging and health issues. Worse still, NAD+ is a large molecule easily destroyed in digestion and cannot be directly absorbed by cells. Thus, “supplementing precursors and converting internally” has become the core path for boosting NAD+.

PART 02
Detailed Look at NAD+ Family Members: Pros and Cons
The NAD+ family mainly includes five precursors (NMN, NR, NA, NAM, Trp). They differ significantly in conversion efficiency, safety, and suitable application scenarios.
1. Controversial Candidates: NA (Nicotinic Acid) & NAM (Nicotinamide)
— More side effects, lower efficiency
NA and NAM, both Vitamin B3 derivatives, were the earliest NAD+ precursors discovered. Though common in organ meats, vegetables, and fruits, their use as anti-aging supplements faces major limitations:
- NA: While effective in raising NAD+ levels, high doses (>30 mg) may cause side effects such as low blood pressure, nausea, abdominal pain, or even more serious issues like vision damage and hyperglycemia at 1000 mg/day.
- NAM: Though capable of raising NAD+ levels, its efficiency is limited by the rate-limiting enzyme NAMPT. Moreover, NAM inhibits Sirtuin activity, restricting its anti-aging potential. High doses can cause liver toxicity.
2. Inefficient Candidate: Trp (Tryptophan)
— Too many conversion steps, minimal contribution

Trp, an essential amino acid found in dairy, meat, and soy, can generate NAD+ through the de novo pathway. However, this requires 8 enzymatic steps, and most Trp is consumed in serotonin and melatonin synthesis. Its NAD+ contribution is minimal.
3. Potential Candidate: NR (Nicotinamide Riboside)
— Natural source, safe choice

NR, found naturally in milk, was discovered in 1944 and introduced into anti-aging research in 2004. It must first convert to NMN, then to NAD+. Despite this two-step conversion, studies consistently validate NR’s ability to raise blood NAD+ levels. Its well-established industrial production makes NR affordable and safe, ideal for long-term daily use to maintain baseline NAD+ levels.
4. Star Candidate: NMN (Nicotinamide Mononucleotide)
— Direct precursor, efficient and safe

NMN is a direct precursor of NAD+ and one of the most researched molecules in the NAD+ family. It shows fast absorption and high efficiency, entering the bloodstream within minutes and raising NAD+ levels within half an hour. Research from top journals like *Nature* and *Science* demonstrates its potential to extend lifespan, reverse vascular aging, and protect against neurodegenerative diseases. Human studies confirm that NMN is safe at doses up to 500 mg.
PART 03
The Ultimate Guide: How to Choose Scientifically?
- Prioritize NMN: Best choice for efficiency, safety, and broad applicability. Suitable for those focused on anti-aging and metabolic health.
- Consider NR: A practical, compliant option for those prioritizing safety over maximal efficiency.
- Avoid NA & NAM: Due to side effects and limitations.
- Trp: Only a minor contributor, not suitable for supplementation purposes.
When selecting NAD+ supplements, consult professionals, and follow updates from regulatory and scientific bodies to make evidence-based decisions.

As a pioneer in NAD+ research and production, BonTai Biotech (BONTAC) has developed advanced full-enzyme catalytic technologies, owns 24 NMN patents and the world’s first NR crystalline form patent, and supplies over 1200 companies worldwide, including Harvard’s David Sinclair team. With cutting-edge purification technologies like Bonpure® (99.9% NMN purity), BonTai continues to lead the industry in quality and innovation.